0.08CNY
43.56 MCNY
2.06 BCNY
428.68 M
About HENAN TALOPH PHARMACEUTICAL STOCK CO.,LTD
Sector
CEO
Jing Liang Li
Headquarters
Zhengzhou
Website
Employees (FY)
2.35 K
Founded
1993
ISIN
CNE0000010L8
FIGI
BBG000DGWL43
Henan Taloph Pharmaceutical Stock Co., Ltd. engages in the research, development, production and sale of Chinese patent medicines and Western medicines. It operates through the following segments: Pharmaceutical Preparations, Traditional Chinese Medicine, Drug Research & Development Services, and Drugs & Medicinal Materials Circulation. The Pharmaceutical Preparations segment offers oral liquid products, chewable tablets, and other tablets. The Traditional Chinese Medicine segment provides ordinary decoction pieces and special boutique decoction pieces. The Drug Research & Development Services segment provides pharmaceutical research, production technology research, clinical research, and application & registration services. The Drugs & Medicinal Materials Circulation segment purchases and sells Chinese medicinal materials and products of other pharmaceutical manufacturers. The company was founded in 1993 and is headquartered in Zhengzhou, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 600222 is 4.79 CNY — it has increased by 1.27% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange HENAN TALOPH PHARMACEUTICAL STOCK CO.,LTD stocks are traded under the ticker 600222.
HENAN TALOPH PHARMACEUTICAL STOCK CO.,LTD is going to release the next earnings report on Apr 26, 2024. Keep track of upcoming events with our Earnings Calendar.
600222 stock is 5.41% volatile and has beta coefficient of 1.14. Check out the list of the most volatile stocks — is HENAN TALOPH PHARMACEUTICAL STOCK CO.,LTD there?
Yes, you can track HENAN TALOPH PHARMACEUTICAL STOCK CO.,LTD financials in yearly and quarterly reports right on TradingView.
600222 stock has fallen by 13.07% compared to the previous week, the month change is a 9.96% fall, over the last year HENAN TALOPH PHARMACEUTICAL STOCK CO.,LTD has showed a 20.17% decrease.
600222 net income for the last quarter is 60.48 M CNY, while the quarter before that showed 21.41 M CNY of net income which accounts for 182.56% change. Track more HENAN TALOPH PHARMACEUTICAL STOCK CO.,LTD financial stats to get the full picture.
Today HENAN TALOPH PHARMACEUTICAL STOCK CO.,LTD has the market capitalization of 2.65 B, it has decreased by 2.64% over the last week.
Like other stocks, 600222 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HENAN TALOPH PHARMACEUTICAL STOCK CO.,LTD stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 20, 2024, the company has 2.35 K employees. See our rating of the largest employees — is HENAN TALOPH PHARMACEUTICAL STOCK CO.,LTD on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HENAN TALOPH PHARMACEUTICAL STOCK CO.,LTD technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HENAN TALOPH PHARMACEUTICAL STOCK CO.,LTD stock shows the sell signal. See more of HENAN TALOPH PHARMACEUTICAL STOCK CO.,LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HENAN TALOPH PHARMACEUTICAL STOCK CO.,LTD EBITDA is 160.38 M CNY, and current EBITDA margin is 7.79%. See more stats in HENAN TALOPH PHARMACEUTICAL STOCK CO.,LTD financial statements.